125568-73-2 Usage
General Description
Methyl 5-amino-2,4-difluorobenzoate is a chemical compound with the molecular formula C8H7F2NO2. It is an organic compound that contains a methyl ester group, an amino group, and two fluorine atoms attached to a benzene ring. Methyl 5-amino-2,4-difluorobenzoate has a white crystalline appearance and is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It has a wide range of applications in the chemical industry, including as a building block for the production of various drugs and pesticides. Methyl 5-amino-2,4-difluorobenzoate is also used as a research chemical in laboratories for its unique properties and potential use in organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 125568-73-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,5,6 and 8 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 125568-73:
(8*1)+(7*2)+(6*5)+(5*5)+(4*6)+(3*8)+(2*7)+(1*3)=142
142 % 10 = 2
So 125568-73-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H7F2NO2/c1-13-8(12)4-2-7(11)6(10)3-5(4)9/h2-3H,11H2,1H3
125568-73-2Relevant articles and documents
NON BRAIN PENETRANT A2A INHIBITORS AND METHODS FOR USE IN THE TREATMENT OF CANCERS
-
Paragraph 1701-1702, (2020/04/24)
The present invention relates to compounds of Formula (I) or pharmaceutically acceptable salts thereof. The invention further relates to the use of the compounds of Formula (I) as A2A inhibitors. The invention also relates to the use of the compounds of F
CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS
-
Page/Page column 22, (2009/07/17)
The present invention relates to compounds useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acq
CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS
-
Page/Page column 12, (2009/06/27)
The present invention relates to compounds useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).